FDA applicant

Asset Medikal Tasarim San Tic As.

Istanbul, TR1 decision2023–20230 recalls

FDA records 1 decision for Asset Medikal Tasarim San Tic As. (Istanbul, TR) in 2023: 1 510(k) clearance. All are in product code FPA (Set, Administration, Intravascular). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Asset Medikal Tasarim San Tic As.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2023high 1 (2023) · low 0 (2024)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2023.

FIG. 1 — Asset Medikal Tasarim San Tic As. by year, 2023–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Asset Medikal Tasarim San Tic As.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Asset”

FDA records each applicant name separately; these may or may not be the same firm.

Asset Medikal Tasarim As. 4 Asset Medikal Tasarim Sanayi VE Ticaret A.S. 1 Asset Scientific & Pharmaceutical, Inc. 1 Asset Ent., Sdn Bhd 1 Asset Medikal 1

Asset Medikal Tasarim San Tic As.

Which product codes does it file in?

What has FDA decided for it lately?

Other applicant names beginning “Asset”